GE HealthCare Technologies (GEHC) said Tuesday it has received 510(k) clearance from the US Food and Drug Administration for its updated portfolio of Voluson Expert Series ultrasound systems.
The company said the Voluson Expert 22, 20, and 18 systems integrate artificial intelligence tools to enhance imaging quality and streamline workflows.
GE Healthcare said it plans to showcase the systems at the Society for Maternal-Fetal Medicine meeting in Denver.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.